Status | Study |
Recruiting |
Study Name: Familial Investigations of Childhood Cancer Predisposition Condition: Acute Leukemia Adenomatous Polyposis Adrenocortical Carcin Date: 2017-02-08 |
Not yet recruiting |
Study Name: Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor Condition: Functional Pancreatic Neuroendocrine Tumor Malignant Somatostatinoma Date: 2016-07-10 Interventions: Drug: Capecitabine Given PO |
Completed |
Study Name: Study of Molecular Pathways in Medullary Thyroid Carcinoma and Correlation of Molecular Data With Clinical Behavior of the MTC in Individuals Patients Condition: Medullary Thyroid Carcinoma Multiple Endocrine Neoplasia Type 2 Date: 2011-08-26 |
Active, not recruiting |
Study Name: Vandetanib to Treat Children and Adolescents With Medullary Thyroid Cancer Condition: Medullary Thyroid Carcinoma Multiple Endocrine Neoplasia Type 2 Date: 2007-08-08 Interventions: Drug: Vandetanib once daily continuously (28 day cycles) |